Skip to main content

and
  1. No Access

    Article

    Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention

    Clopidogrel is an antiplatelet drug given to patients before and after having a percutaneous coronary intervention (PCI). Genomic variants in the CYP2C19 gene are associated with variable enzyme activities affect...

    Vasilios Fragoulakis, Marina Bartsakoulia in The Pharmacogenomics Journal (2019)